AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Aion Therapeutic Inc.

$0 +$0.00 (+17.65%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0.02
Market Cap
2.07M
AVG Volume
1.2K
Trailing/Forward PE
-0.21/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD)
0200K400K600K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Revenue (CAD) by quarter
PeriodRevenue (CAD)
25 Q3544.99K
25 Q2347.62K
25 Q1434.86K
24 Q4145.44K
24 Q3222.04K
24 Q20
24 Q10
23 Q40
23 Q30
23 Q20
Net Income (CAD)
-6M-4M-2M023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Net Income (CAD) by quarter
PeriodNet Income (CAD)
25 Q3-292.46K
25 Q2-582.81K
25 Q1-370.81K
24 Q4-5.4M
24 Q3-377.95K
24 Q2-181.36K
24 Q1-328.58K
23 Q4-723.45K
23 Q3-215.72K
23 Q2-125.58K
Operating Income (CAD)
-600K-400K-200K023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
25 Q3-240.05K
25 Q2-512.97K
25 Q1-271.63K
24 Q4-512.02K
24 Q3-214.92K
24 Q2-269.09K
24 Q1-165.3K
23 Q4-278.42K
23 Q3-246.96K
23 Q2-227.38K
EBITDA (CAD)
-6M-4M-2M023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
25 Q3-93.54K
25 Q2-489.76K
25 Q1-288.93K
24 Q4-5.32M
24 Q3-314.65K
24 Q2-141.82K
24 Q1-165.3K
23 Q4-278.29K
23 Q3-167.41K
23 Q2-221.59K
Cash Flows (CAD)
-1M-500K0500K23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
25 Q3-43.71K
25 Q2-148.27K
25 Q1-544.93K
24 Q4-808.88K
24 Q3243.24K
24 Q2-43.81K
24 Q1-235.59K
23 Q4151.56K
23 Q3-119.77K
23 Q27.96K
EPS (CAD)
-0.01-0.01-0023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF EPS (CAD) by quarter
PeriodEPS (CAD)
25 Q3-0
25 Q2-0
25 Q1-0
24 Q4-0.01
24 Q3-0
24 Q2-0
24 Q1-0
23 Q4-0
23 Q3-0
23 Q2-0
Expenses (CAD)
0200K400K600KR&DSG&ACapex23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Expenses (CAD) by quarter
PeriodExpenses (CAD)
25 Q3312.47K
25 Q2528.44K
25 Q1405.05K
24 Q4391.86K
24 Q3318.64K
24 Q2209.09K
24 Q1101.79K
23 Q4108.06K
23 Q3124.83K
23 Q2122.97K
Cash & Debt (CAD)
01M2M3MCashLong Term DebtShort Term Debt23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
25 Q313.82K
25 Q293.69K
25 Q180.96K
24 Q468.34K
24 Q3349.28K
24 Q2926
24 Q133.92K
23 Q4336
23 Q30
23 Q213.47K
Debt ratios
-2-1.5-1-0.5023 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Debt ratios by quarter
PeriodDebt ratios
25 Q3-0.45
25 Q2-0.36
25 Q1-0.4
24 Q4-0.34
24 Q3-1.87
24 Q2-1.38
24 Q1-1.17
23 Q4-1
23 Q3-0.41
23 Q2-0.38
Margins
-20%0%20%40%60%80%24 Q324 Q425 Q125 Q225 Q3
ANTCF Margins by quarter
PeriodMargins
25 Q339.25%
25 Q241.91%
25 Q144.48%
24 Q4-0.42%
24 Q373.73%
Return on Capital
-50%0%50%100%150%23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Return on Capital by quarter
PeriodReturn on Capital
25 Q36.26%
25 Q214.19%
25 Q19.15%
24 Q4139.45%
24 Q3-36.59%
24 Q26.74%
24 Q112.08%
23 Q426.54%
23 Q311.59%
23 Q27.21%
Shares Outstanding
0200M400M600M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Shares Outstanding by quarter
PeriodShares Outstanding
25 Q3497.15M
25 Q2484.01M
25 Q1363.72M
24 Q4411.55M
24 Q3316.02M
24 Q2190.32M
24 Q1147.3M
23 Q4147.3M
23 Q3147.3M
23 Q2147.3M
Book Value Per Share (CAD)
-0.02-0.0100.0123 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
25 Q3-0.01
25 Q2-0.01
25 Q1-0.01
24 Q4-0.01
24 Q30
24 Q2-0.01
24 Q1-0.02
23 Q4-0.02
23 Q3-0.01
23 Q2-0.01
Total Assets (CAD)
02M4M6M23 Q223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q3
ANTCF Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
25 Q31.21M
25 Q21.54M
25 Q11.22M
24 Q4702.86K
24 Q35.89M
24 Q2329.86K
24 Q1151.36K
23 Q4210.67K
23 Q3627.59K
23 Q2698.76K
Free Cash Flow Yield
-200%-150%-100%-50%0%med -111.05%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ANTCF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-112.8%
Sep 26-112.4%
Aug 26-111.84%
Aug 26-112.96%
Aug 26-112.07%
Aug 26-111.56%
Jul 26-110.95%
Jul 26-110.32%
Jul 26-110.89%
Jul 26-109.87%
Jul 26-109.63%
Jun 26-109.58%
Jun 26-109.97%
Jun 26-111.15%
Jun 26-111.55%
May 26-112.76%
May 26-112.54%
May 26-113.11%
May 26-113.69%
May 26-114.44%
Apr 26-113.77%
Apr 26-113.57%
Apr 26-112.34%
Apr 26-111.7%
Mar 26-111.93%
Mar 26-113.33%
Mar 26-113.31%
Mar 26-134.89%
Feb 26-134.12%
Feb 26-133.77%
Feb 26-134.35%
Feb 26-133.8%
Jan 26-134.33%
Jan 26-133.54%
Jan 26-131.46%
Jan 26-131.49%
Jan 26-133.24%
Dec 25-133.79%
Dec 25-132.58%
Dec 25-132.83%
Dec 25-132.4%
Nov 25-14.84%
Nov 25-14.7%
Nov 25-12.32%
Nov 25-130.23%
Oct 25-130.63%
Oct 25-130.71%
Oct 25-130.48%
Oct 25-130.68%
Oct 25-131.17%
Sep 25-131.23%
Sep 25-132.81%
Sep 25-132.12%
Sep 25-132.31%
Aug 25-133.14%
Aug 25-132.35%
Aug 25-132.41%
Aug 25-132.98%
Aug 25-132.66%
Jul 25-174.62%
Jul 25-56.66%
Jul 25-56.8%
Jul 25-57.23%
Jun 25-56.83%
Jun 25-56.61%
Jun 25-57.25%
Jun 25-19.09%
May 25-56.6%
May 25-56.63%
May 25-55.66%
May 25-55.8%
May 25-56.28%
Apr 25-34.15%
Apr 25-34.19%
Apr 25-34.11%
Apr 25-33.24%
Mar 25-33.04%
Mar 25-32.96%
Mar 25-32.91%
Mar 25-32.93%
Feb 25-32.71%
Feb 25-33.27%
Feb 25-28.22%
Feb 25-26.01%
Jan 25-16.28%
Jan 25-20.12%
Jan 25-19.93%
Jan 25-61.16%
Jan 25-14.27%
Dec 24-14.3%
Dec 24-53.87%
Dec 24-54.41%
Dec 24-54.71%
Nov 24-7.56%
Nov 24-21.64%
Nov 24-39.54%
Nov 24-9.13%
Nov 24-39.24%
Oct 24-13.08%
Oct 24-13.29%
Price to Sales
05101520med 0.95Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ANTCF Price to Sales by quarter
PeriodPrice to Sales
Sep 260.93
Sep 260.93
Aug 260.94
Aug 260.93
Aug 260.94
Aug 260.94
Jul 260.95
Jul 260.95
Jul 260.95
Jul 260.96
Jul 260.96
Jun 260.96
Jun 260.95
Jun 260.94
Jun 260.94
May 260.93
May 260.93
May 260.93
May 260.92
May 260.92
Apr 260.92
Apr 260.92
Apr 260.93
Apr 260.94
Mar 260.94
Mar 260.93
Mar 260.93
Mar 260.78
Feb 260.78
Feb 260.78
Feb 260.78
Feb 260.78
Jan 260.78
Jan 260.79
Jan 260.8
Jan 260.8
Jan 260.79
Dec 250.78
Dec 250.79
Dec 250.79
Dec 250.79
Nov 257.07
Nov 257.14
Nov 258.52
Nov 250.81
Oct 250.8
Oct 250.8
Oct 250.8
Oct 250.8
Oct 250.8
Sep 250.8
Sep 250.79
Sep 250.79
Sep 250.79
Aug 250.79
Aug 250.79
Aug 250.79
Aug 250.79
Aug 250.79
Jul 250.6
Jul 251.85
Jul 251.85
Jul 251.83
Jun 251.85
Jun 251.85
Jun 251.83
Jun 255.5
May 251.85
May 251.85
May 251.89
May 251.88
May 251.86
Apr 253.21
Apr 253.2
Apr 253.21
Apr 253.29
Mar 253.31
Mar 253.32
Mar 253.33
Mar 253.32
Feb 253.35
Feb 253.29
Feb 253.88
Feb 254.21
Jan 256.72
Jan 257.15
Jan 257.22
Jan 252.35
Jan 2510.08
Dec 2410.06
Dec 242.67
Dec 242.64
Dec 242.63
Nov 2419.04
Nov 246.65
Nov 243.64
Nov 2415.76
Nov 243.67
Oct 2417.58
Oct 2417.31
Price/Operating Cashflow
1020304050med 25.66May 24May 24Jul 24Jul 24
ANTCF Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Jul 2425.76
Jul 2425.56
May 2440.97
May 2414.22
Price to Book
0102030med 4.59Apr 21Jun 21Jul 21Sep 21Nov 21Jan 22Jul 24
ANTCF Price to Book by quarter
PeriodPrice to Book
Jul 242.88
Jul 242.86
May 244.58
May 241.59
Jan 224.81
Jan 225.86
Jan 224.94
Jan 223.55
Dec 214.59
Dec 214.64
Dec 214.64
Dec 215.32
Nov 214.61
Nov 214.44
Nov 214.52
Oct 214.67
Oct 214.66
Oct 215.94
Oct 2112.92
Oct 217.42
Sep 2110.19
Sep 2117.48
Sep 2115.39
Sep 2120.89
Aug 2122.69
Aug 2126.65
Aug 2124.95
Aug 2123.54
Jul 2127.34
Jul 212.16
Jul 212.23
Jul 212.15
Jul 212.39
Jun 212.41
Jun 212.28
Jun 212.41
Jun 212.39
May 212.44
May 212.53
May 212.41
May 212.18
Apr 211.97
Apr 211.98
Aion Therapeutic Inc.
ANTCF
Stockpicker

Video analysis: ANTCF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.